Other
Clinical Laboratory Services
Total Trials
3
Recruiting
0
Active
0
Completed
2
Success Rate
100.0%+13% vs avg
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 15/100
Failure Rate
0.0%
0 terminated/withdrawn out of 3 trials
Success Rate
100.0%
+13.5% vs industry average
Late-Stage Pipeline
67%
2 trials in Phase 3/4
Results Transparency
50%
1 of 2 completed trials have results
Key Signals
1 with results
Enrollment Performance
Analytics
Phase 3
2(100.0%)
2Total
Phase 3(2)
Activity Timeline
Global Presence
Loading network data...
Clinical Trials (3)
Showing 3 of 3 trials
NCT02374450Completed
A Surveillance Study of Diseases Specified as Adverse Events of Special Interest, of Other Adverse Events Leading to Hospitalisation or Death, and of Meningitis in Children in Africa Prior to Implementation of the RTS,S/AS01E Candidate Vaccine
Role: collaborator
NCT05148845Phase 3Unknown
Sisonke 2 - A COVID-19 Vaccine Boost Open Label Study.
Role: collaborator
NCT04838795Phase 3Completed
Sisonke (Together): OPEN LABEL TRIAL COVID-19
Role: collaborator
All 3 trials loaded